Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, October 25, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Venture Capital
Venture Capital
Venture Capital
Estuary Biotherapeutics Launches with $103 Million to Advance Gene Therapies for Kidney Disease
Life Sciences Times
-
October 16, 2026
Venture Capital
Acta Pharmaceuticals Raises $24 Million to Advance Alzheimer’s Disease Treatments
Life Sciences Times
-
October 15, 2026
Venture Capital
Soufflé Therapeutics Raises $135 Million in Series B Financing to Advance RNA Therapies
Life Sciences Times
-
October 13, 2026
Venture Capital
Consano Bio Raises More Than $15 Million to Advance Chronic Sciatica Therapy
Life Sciences Times
-
October 5, 2026
Venture Capital
ai3Bio Launches With $48 Million Series A to Advance Autoimmune Disease Therapies
Life Sciences Times
-
September 29, 2026
Venture Capital
Gamida Cell Announces Closing of $25 Million Financing With Highbridge
Life Sciences Times
-
December 12, 2022
0
Venture Capital
Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform
Life Sciences Times
-
December 12, 2022
0
Venture Capital
Green Rock Energy Partners Acquires Pennsylvania Renewable Natural Gas Production Facility
Life Sciences Times
-
December 8, 2022
0
Venture Capital
Cognex Acquires German Lighting Technology Provider SAC
Life Sciences Times
-
December 8, 2022
0
Venture Capital
SIMPLEX QUANTUM, Inc. Raises Round of Series A Funding
Life Sciences Times
-
December 7, 2022
0
Venture Capital
Avalon BioVentures Raises First Fund Dedicated to Early-Stage Biotech Investments
Life Sciences Times
-
December 6, 2022
0
Venture Capital
Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement
Life Sciences Times
-
December 6, 2022
0
Venture Capital
EndoGastric Solutions, Inc.® Announces CEO Transition and $18M Financing to Expand Commercialization
Life Sciences Times
-
December 6, 2022
0
Venture Capital
Cisco Investments and Third Culture Capital Among Notable Investors in Voiceitt’s Latest Funding Round to Scale its Accessible Speech Recognition
Life Sciences Times
-
December 2, 2022
0
Venture Capital
Surgical Innovation Associates (SIA) Announces Definitive Agreement to be Acquired by Integra LifeSciences
Life Sciences Times
-
December 1, 2022
0
Medtech
Belgian Company Minze Health Raises €3.9m to Further Scale Its Digital Health Solutions for the Treatment of Urinary Tract Problems
Life Sciences Times
-
December 1, 2022
0
Venture Capital
Liminatus Pharma LLC and Iris Acquisition Corp to combine to incorporate and accelerate much-needed cancer treatments
Life Sciences Times
-
December 1, 2022
0
1
...
57
58
59
...
115
Page 58 of 115
Most Read
Alnylam Reports Promising Phase 1b Results for Experimental Huntington’s Disease Treatment
October 23, 2026
Zai Lab Reports Promising Early Results for Experimental Small Cell Lung Cancer Treatment
October 23, 2026
Takeda Reports Improved Survival in Phase 3 Trial of Experimental Gastric Cancer Treatment
October 23, 2026
Convergent Therapeutics Reports Promising Phase 2 Results for Prostate Cancer Treatment
October 23, 2026